CEMI - Chembio Diagnostics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue17,868.84124,255.48527,645.284
Cost of Revenue9,417.50513,768.65816,831.261
Gross Profit8,451.33610,486.82710,814.023
Operating Expenses
Research Development8,427.5546,377.8394,832.537
Selling General and Administrative7,595.5597,663.0357,531.739
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-7,571.777-3,554.047-1,550.253
Income from Continuing Operations
Total Other Income/Expenses Net25.548-2.4020.132
Earnings Before Interest and Taxes-7,546.229-3,556.449-1,550.121
Interest Expense-0.8360.836
Income Before Tax-7,546.229-3,557.285-1,550.121
Income Tax Expense5,800.818-1,160.243-412.918
Minority Interest---
Net Income From Continuing Ops-13,347.047-2,397.042-1,137.203
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,347.047-2,397.042-1,137.203
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,347.047-2,397.042-1,137.203